Risk stratification and outcomes in hemodynamically stable patients with acute pulmonary embolism: a prospective, multicentre, cohort study with three months of follow-up

被引:68
作者
Bova, C. [1 ]
Pesavento, R. [2 ]
Marchiori, A. [3 ]
Palla, A. [4 ]
Enea, I. [5 ]
Pengo, V. [2 ]
Visona, A. [6 ]
Noto, A. [1 ]
Prandoni, P. [2 ]
机构
[1] Azienda Osped, Dept Internal Med, Cosenza, Italy
[2] Univ Padua, Dept Cardiothorac & Vasc Sci, Padua, Italy
[3] S Anthony Hosp, Dept Emergency Med, Padua, Italy
[4] Univ Pisa, Cardiothorac Dept, Pisa, Italy
[5] Osped S Sebastiano, Emergency Dept, Caserta, Italy
[6] Osped S Giacomo, Angiol Dept, Castelfranco Veneto, Italy
关键词
hemodynamic stable; prognosis; pulmonary embolism; RIGHT-VENTRICULAR DYSFUNCTION; PROGNOSTIC VALUE; ECHOCARDIOGRAPHY; MANAGEMENT; ALTEPLASE; PRESSURE; HEPARIN;
D O I
10.1111/j.1538-7836.2009.03345.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The role of risk stratification in normotensive patients with acute pulmonary embolism (PE) is still unclear. Objectives: We evaluated, in these patients, the usefulness of six prognostic markers for predicting in-hospital adverse events related to PE and 3-month mortality. Patients/Methods: Two hundred and one consecutive patients with confirmed acute PE and normal blood pressure, who were administered conventional anticoagulation, were recruited in a multicentre prospective cohort study with 3 months of follow-up. At baseline, they received a comprehensive risk-evaluation including echocardiographic assessment of right ventricular dysfunction, determination of troponin I, brain natriuretic peptide and D-dimer, arterial blood gas analysis and a clinical score. Primary outcome of the study was PE-related in-hospital death or clinical deterioration. Secondary outcomes were in-hospital and 3-month all-cause mortality. Results: The primary outcome occurred in one patient (0.5%), who died from PE during hospitalization. The in-hospital and 3-month all-cause mortality were 2% and 9%, respectively. None of the prognostic markers was predictive of the primary outcome. Clinical score, troponin I and hypoxemia predicted in-hospital all-cause mortality (P = 0.02, 0.01 and < 0.01, respectively). Clinical score (HR, 4.7; 95% CI, 1.9-12.0), D-dimer (4.8; 1.4-16.3), hypoxemia (5.7; 2.1-15.1) and troponin I (7.5; 2.5-22.7) were predictors of 3-month all-cause mortality on univariate analysis. On multivariate analysis clinical score and troponin I remained independently predictive. Conclusions: We did not find prognostic markers useful as predictors of in-hospital PE-related adverse events. Clinical score, troponin I and hypoxemia predicted in-hospital all-cause mortality. Clinical score and troponin I independently predicted 3-month all-cause mortality.
引用
收藏
页码:938 / 944
页数:7
相关论文
共 27 条
[1]   Derivation and validation of a prognostic model for pulmonary embolism [J].
Aujesky, D ;
Obrosky, DS ;
Stone, RA ;
Auble, TE ;
Perrier, A ;
Cornuz, J ;
Roy, PM ;
Fine, MJ .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2005, 172 (08) :1041-1046
[2]   Prognostic value of D-dimer in patients with pulmonary embolism [J].
Aujesky, Drahomir ;
Roy, Pierre-Marie ;
Guy, Meyer ;
Cornuz, Jacques ;
Sanchez, Olivier ;
Perrier, Arnaud .
THROMBOSIS AND HAEMOSTASIS, 2006, 96 (04) :478-482
[3]   Prognostic value of troponins in acute pulmonary embolism - A meta-analysis [J].
Becattini, Cecilia ;
Vedovati, Maria Cristina ;
Agnelli, Giancarlo .
CIRCULATION, 2007, 116 (04) :427-433
[4]   Antithrombotic therapy for venous thromboembolic disease [J].
Büller, HR ;
Agnelli, G ;
Hull, RD ;
Hyers, TA ;
Prins, AH ;
Raskob, GE .
CHEST, 2004, 126 (03) :401S-428S
[5]   THE CLINICAL COURSE OF PULMONARY-EMBOLISM [J].
CARSON, JL ;
KELLEY, MA ;
DUFF, A ;
WEG, JG ;
FULKERSON, WJ ;
PALEVSKY, HI ;
SCHWARTZ, JS ;
THOMPSON, BT ;
POPOVICH, J ;
HOBBINS, TE ;
SPERA, MA ;
ALAVI, A ;
TERRIN, ML .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (19) :1240-1245
[6]   Risk of fatal pulmonary embolism in patients with treated venous thromboembolism [J].
Douketis, JD ;
Kearon, C ;
Bates, S ;
Duku, EK ;
Ginsberg, JS .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (06) :458-462
[7]   Echocardiography in the management of pulmonary embolism [J].
Goldhaber, SZ .
ANNALS OF INTERNAL MEDICINE, 2002, 136 (09) :691-700
[8]   Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER) [J].
Goldhaber, SZ ;
Visani, L ;
De Rosa, M .
LANCET, 1999, 353 (9162) :1386-1389
[9]   ALTEPLASE VERSUS HEPARIN IN ACUTE PULMONARY-EMBOLISM - RANDOMIZED TRIAL ASSESSING RIGHT-VENTRICULAR FUNCTION AND PULMONARY PERFUSION [J].
GOLDHABER, SZ ;
HAIRE, WD ;
FELDSTEIN, ML ;
MILLER, M ;
TOLTZIS, R ;
SMITH, JL ;
DASILVA, AMT ;
COME, PC ;
LEE, RT ;
PARKER, JA ;
MOGTADER, A ;
MCDONOUGH, TJ ;
BRAUNWALD, E .
LANCET, 1993, 341 (8844) :507-511
[10]  
Goldhaber SZ, 2001, THROMB HAEMOSTASIS, V86, P444